Results 171 to 180 of about 56,286 (316)
Determination of Acid α-Glucosidase Protein: Evaluation as a Screening Marker for Pompe Disease and Other Lysosomal Storage Disorders [PDF]
Kandiah Umapathysivam +7 more
openalex +1 more source
Intrauterine enzyme replacement therapies for lysosomal storage disorders: Current developments and promising future prospects. [PDF]
Herzeg A +13 more
europepmc +1 more source
Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder [PDF]
Chiara Di Malta +3 more
openalex +1 more source
Neurodegenerative Lysosomal Storage Disorders: TPC2 Comes to the Rescue! [PDF]
Prat Castro S +5 more
europepmc +1 more source
Pompe disease: Shared and unshared features of lysosomal storage disorders [PDF]
Jeong‐A Lim +4 more
openalex +1 more source
The transition period in dairy cows, spanning 3 weeks before and after calving, is a critical phase characterized by increased nutrient demands, reduced dry matter intake (DMI), and elevated risk of metabolic disorders such as negative nutrient balance (NNB), lipolysis, proteolysis, and oxidative stress.
Mohammed S. Seleem +5 more
wiley +1 more source
A kaleidoscopic view of extracellular vesicles in lysosomal storage disorders. [PDF]
Hegeman CV, de Jong OG, Lorenowicz MJ.
europepmc +1 more source
Objective Bone destruction associated with active rheumatoid arthritis (RA) remains a major therapeutic challenge, with a lack of reliable molecular markers reflecting bone injury. This study aims to identify novel biomarkers linked to bone destruction in active RA through proteomic analysis, providing new strategies for precise monitoring and targeted
Pengfei Xin +15 more
wiley +1 more source

